BIOMARKER:

Chr del(17)(p13.1)

B | Sensitive

C3 | Sensitive

B | Resistant

C3 | Resistant

Show legend

Drug categories

Tyrosine Kinase Inhibitors

CD Protein Inhibitors

Immunotherapy

Chronic Lymphocytic Leukemia

Small Lymphocytic Lymphoma

acalabrutinib

Chr del(17)(p13.1)|Chronic Lymphocytic Leukemia|acalabrutinib

Chr del(17)(p13.1)|Small Lymphocytic Lymphoma|acalabrutinib

obinutuzumab + acalabrutinib

Chr del(17)(p13.1)|Chronic Lymphocytic Leukemia|obinutuzumab + acalabrutinib

ibrutinib + rituximab

Chr del(17)(p13.1)|Chronic Lymphocytic Leukemia|ibrutinib + rituximab

alemtuzumab

Chr del(17)(p13.1)|Chronic Lymphocytic Leukemia|alemtuzumab

obinutuzumab

Chr del(17)(p13.1)|Chronic Lymphocytic Leukemia|obinutuzumab

ibrutinib

Chr del(17)(p13.1)|Chronic Lymphocytic Leukemia|ibrutinib